MEDIHEAL Madecassoside Blemish Pad 100 Pads

MEDIHEAL Madecassoside Blemish Pad 100 Pads

100Pads
$48.99
Skip to product information
MEDIHEAL Madecassoside Blemish Pad 100 Pads

MEDIHEAL Madecassoside Blemish Pad 100 Pads

$48.99
Option100Pads

Free shipping on orders $50+. You'll be $1.01 away with this item.

  • Sourced and shipped from Korea
  • Secure checkout

MEDIHEAL Madecassoside Blemish Pad 100 Pads features Centella asiatica extract (1,001 ppm), madecassoside (10.25 ppm), and niacinamide for skin-conditioning care.

Glycerin and glycereth-26 help retain moisture, while allantoin and dipotassium glycyrrhizate complement the formula for comfortable-feeling skin.

Centella root and leaf extracts, fermented ingredients, and emollients provide additional conditioning care, leaving skin feeling soft and smooth.

Ingredients

Water, Dipropylene Glycol, Glycereth-26, Niacinamide, Glycerin, 1,2-Hexanediol, Diphenyl Dimethicone, Triethylhexanoin, Hydroxyacetophenone, Hydrogenated Lecithin, Polyglyceryl-10 Oleate, Centella Asiatica Extract (1,001 ppm), Dipotassium Glycyrrhizate, Sodium Citrate, Allantoin, Octyldodeceth-16, Citric Acid, Disodium EDTA, Polyglyceryl-10 Laurate, Juniperus Virginiana Oil, Butylene Glycol, Artemisia Vulgaris Oil, Pogostemon Cablin Oil, Madecassoside (10.25 ppm), Rosmarinus Officinalis (Rosemary) Leaf Oil, Viola Odorata Leaf Extract, Centella Asiatica Root Extract, Centella Asiatica Leaf Extract, Yeast Ferment, Mangifera Indica (Mango) Fruit Extract, Lactobacillus Ferment, Asiaticoside, Madecassic Acid, Asiatic Acid.

Why buying direct matters

The most-loved K-beauty is also the most-faked. Everything at Áine is sourced from suppliers in Korea and ships straight from Korea to your door, not from random marketplace sellers.

Sourced in KoreaShips from Korea in 7–14 daysNo marketplace resellers

See the facts

Copycat Beauty of Joseon sunscreen has turned up on Amazon and TikTok Shop with packaging that copies the real thing, and a seized fake SK-II essence had no detectable niacinamide. Worth the short wait for the real thing.

Reported by Korea JoongAng Daily and Korean Intellectual Property Office.

You may also like